Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 76420-945

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 76420-945). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

This is a statistical data table showing cumulative incidence percentages at different time points (20, 25, 30, and 35 years). The data compares the outcomes between Atorvastatin and Placebo, with a Hazard Ratio (HR) of 0.64 and a p-value of 0.0005. It provides valuable information on the impact of Atorvastatin compared to Placebo over a long-term period.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

This text provides statistical information on the cumulative hazard percentage for a placebo and Atorvastatin treatment. It includes hazard ratio (HR), confidence intervals, and p-value for the comparison. Additionally, it presents the time to the first primary endpoint over four years of follow-up.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

This text provides data on the subjects experiencing an event with different doses of Atorvastatin. It also includes hazard ratio (HR) values and the time to the first major cardiovascular endpoint in years.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

FDA Label Image

10 (Label 10mg)

FDA Label Image

20 (Label 20mg)

FDA Label Image

40 (Label 40mg)

FDA Label Image

80 (Label 80mg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.